RNTX

Rein Therapeutics, Inc. Common Stock
RNTX

Overview Fund Activity

33 hedge funds and large institutions have $5.86M invested in Rein Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
-4
Holders Change %
-10.81%
% of All Funds
0.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
8
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
William Blair & Company
William Blair & Company
Illinois
$254K
2
Renaissance Technologies
Renaissance Technologies
New York
$39K
3
Envestnet Asset Management
Envestnet Asset Management
Illinois
$38K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$10K
5
Osaic Holdings
Osaic Holdings
Arizona
$14K

Top Sellers

1
IC
Ikarian Capital
Texas
$0
2
Vanguard Group
Vanguard Group
Pennsylvania
$539K
3
BFM
Boothbay Fund Management
New York
$0
4
KL
KCK Ltd
Bermuda
$101K
5
TCA
Taconic Capital Advisors
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Millennium Management
26
Millennium Management
New York
$2K +$2K +600 New
BlackRock
27
BlackRock
New York
$1K – – –
Bank of America
28
Bank of America
North Carolina
$1K – – –
IC
29
Ikarian Capital
Texas
– -$752K -144,616 Closed
BFM
30
Boothbay Fund Management
New York
– -$72K -13,937 Closed
TCA
31
Taconic Capital Advisors
New York
– -$35K -6,750 Closed
Jane Street
32
Jane Street
New York
– -$20K -3,792 Closed
TSS
33
Two Sigma Securities
New York
– -$20K -3,754 Closed
TRCT
34
Tower Research Capital (TRC)
New York
– -$9K -1,685 Closed
VF
35
Virtu Financial
New York
– -$5K -1,030 Closed
1
2